drugset / Trial / NCT01536249

Dexpramipexole and Cimetidine Drug Drug Interaction (DDI)

NCT01536249

Phase 1 Completed 14 enrolled Knopp Biosciences
RandomizedCrossoverOpen-labelTreatment

Summary

This study will assess the effect of cimetidine on the pharmacokinetics (PK) of dexpramipexole in healthy volunteer and evaluate the safety and tolerability of dexpramipexole when given with or without cimetidine. Additionally, this study will explore the influence of genetic variation on the PK of dexpramipexole when given with or without cimetidine.

Timeline

Start
2012-03
Primary completion
2012-04
Completion
2012-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Cimetidine Small molecule 400 mg Oral
Subject Dexpramipexole Small molecule 300 mg Oral